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Abstract
Background: Crohn’s disease (CD) is associated with complex pathogenic pathways involving defects in apoptosis
mechanisms. Recently, mesenteric adipose tissue (MAT) has been associated with CD ethiopathology, since adipose
thickening is detected close to the affected intestinal area. However, the potential role of altered apoptosis in MAT of CD
has not been addressed.
Aims: To evaluate apoptosis in the intestinal mucosa and MAT of patients with CD.
Methods: Samples of intestinal mucosa and MAT from patients with ileocecal CD and from non-inflammatory bowel
diseases patients (controls) were studied. Apoptosis was assessed by TUNEL assay and correlated with the adipocytes
histological morphometric analysis. The transcriptional and protein analysis of selected genes and proteins related to
apoptosis were determined.
Results: TUNEL assay showed fewer apoptotic cells in CD, when compared to the control groups, both in the intestinal
mucosa and in MAT. In addition, the number of apoptotic cells (TUNEL) correlated significantly with the area and perimeter
of the adipose cells in MAT. Transcriptomic and proteomic analysis reveal a significantly lower transcript and protein levels
of Bax in the intestinal mucosa of CD, compared to the controls; low protein levels of Bax were found localized in the lamina
propria and not in the epithelium of this tissue. Furthermore, higher level of Bcl-2 and low level of Caspase 3 were seen in
the MAT of CD patients.
Conclusion: The defective apoptosis in MAT may explain the singular morphological characteristics of this tissue in CD,
which may be implicated in the pathophysiology of the disease.
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Introduction
The pathophysiology of CD is not yet completely elucidated,
but environmental factors and inappropriate responses of the
immune system in genetically-susceptible individuals have been
proposed as possible causes of the disease. [1–3] A common
feature in chronic CD with transmural inflammation is hypertro-
phy of the mesenteric adipose tissue (MAT), close to the affected
intestinal area; furthermore, the potential involvement of this
phenomenon in the disease’s pathophysiology has been recently
suggested. This alteration extends from the mesentery, partially
covers the circumference, presents an outer layer of intestinal fat
and may involve the small and large bowel. [4] Differential
expression of adipocytokines and pro-inflammatory cytokines, as
well as, histological alterations have been previously described in
the MAT of CD individuals. [5–8] However, no studies regarding
apoptosis pathways in this tissue have been yet reported.
Apoptosis is a known physiological process of programmed cell
death and is essential for the development and homeostasis of
tissues and organs as well as the elimination of hazards and
abnormal cells. [9,10] In the past 30 years, due to the importance
of this cellular mechanism in many diseases, methods have been
developed for the detection of apoptosis and of the proteins
involved in the process. Apoptosis can be induced by two main
pathways: the intrinsic (mitochondrial), in which Bax is one of the
most important pro-apoptotic protein, and the extrinsic pathways.
[11] In addition, there is a close relationship between these
apoptosis-related pathways and inflammatory pathways. TNF-a,
an important pro-inflammatory cytokine, is involved in the
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Figure 1. TUNEL assay shows different patterns in the intestinal mucosa (ICD) and in the mesenteric adipose tissue (MAT) of
Crohn’s disease (ACD), compared to the respective control biopsy samples (IC and AC). (A) Enterocyte and lamina propria cell apoptosis
are shown by immunofluorescence staining (overlay image); TUNEL+ cells are showed in orange (co-labeled by PI and FITC). Low numbers of TUNEL+
enterocytes and lamina propria cells were detected in the ICD group compared to IC. (C) Adipocyte apoptosis, shown by immunofluorescence
staining (overlay image); TUNEL+ cells are showed in orange (co-labeled by PI and FITC). Low numbers of TUNEL+ adipocytes were detected in the
ACD group compared to AC. Note the high density of TUNEL+ adipocytes, in orange, in the control (AC). Images were obtained using a 40x objective.
(B) and (D) Quantitative analysis of TUNEL staining in the ICD and ACD groups, compared to the respective controls (IC and AC). The graphs of
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activation of apoptosis, while NF-kB has an anti-apoptotic
function, activating the expression of other members of the Bcl-2
family, such as Bcl-2, which prevents cell death [12,13].
While apoptosis in MAT has not yet been investigated in CD,
studies regarding apoptosis in the intestinal tissue of CD patients,
and in other inflammatory bowel diseases, such as, ulcerative
colitis (UC) and in the ileal pouch of UC patients, have been
previously published. [14–16] Reports show that the T cells of CD
mucosa exhibit resistance to a variety of signals that induce
apoptosis, including the differential expression of proteins from the
Bcl-2 family and differences in the ratio between pro and anti-
apoptotic proteins [10,17], suggesting that apoptosis may be one of
the mechanisms involved in CD pathophysiology. Furthermore,
defective apoptosis in immune cells, such as macrophages and
neutrophils, has been reported [18,19].
intestinal tissue show the quantitative analysis for the epithelium and lamina propria TUNEL staining, separately. For ICD, n = 10; for ACD, n = 10; for
IC, n = 8; and, for AC, n = 8, *p,0.05 vs control. (E) Representative hematoxylin-eosin (H&E) staining of fixed paraffin-embedded MAT from AC and
ACD groups shows lower area and perimeter of the adipocytes in the ACD group, compared to the control (AC). Images were obtained using a 40x
objective. (F) Quantitative morphometric histological analysis in the mesenteric adipose tissue (MAT) of Crohn’s disease (ACD), compared to the
respective control group (AC). The graphs show the decreased perimeter (mm) and area (mm2) of the adipocytes from the MAT of Crohn’s disease,
compared to the control biopsy samples. For ACD, n= 10; for AC, n = 8, *p,0.05 vs control. (G) The graphs dispersion show a significant correlation
between the perimeter (mm) and the number of apoptotic cells (TUNEL+), (r = 0.89, p,0.05) and also between the area (mm2) and the number of
apoptotic cells (TUNEL+), (r = 0.92, p,0.05). (H) Immunohistochemical staining of Ki67 in the mesenteric adipose tissue (MAT) of the Crohn’s disease
group (ACD), compared to the control biopsy samples (AC); no evidence of proliferation were found in all samples (ACD, n= 10; AC, n = 8). Images
were obtained using a 40x objective. The positive control was from tissue section of intestinal mucosa.
doi:10.1371/journal.pone.0098547.g001
Figure 2. Bax and Bcl2 gene expressions, as determined by RT-PCR; low transcript levels of Bax and Bcl2 are observed in the
intestinal mucosa of the Crohn’s disease group (ICD), compared to the respective control (IC). Low transcript levels of Bcl2 are also seen
in the mesenteric adipose tissue (MAT) of the Crohn’s disease group (ACD), compared to the respective control (AC), while no differences in Bax
transcripts were found in the MAT groups. For ICD, n = 10; for ACD, n= 10; for IC, n = 8; and, for AC, n = 8, *p,0.05 vs control.
doi:10.1371/journal.pone.0098547.g002
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Whether the thickening of MAT acts as a barrier to the
inflammatory process, or is a secondary factor that maintains the
inflammatory process, resulting in the transmural aspect of CD, is
unknown. [4,20,21] Therefore, this study aimed to evaluate the
potential contribution of apoptosis in accumulation of MAT, as
well as the relationship between altered apoptosis in MAT and in
intestinal tissue involved by CD. To do this, we detected apoptotic
DNA strand breaks using the TUNEL assay, in addition to
analyzing the transcriptional and protein expressions of selected
molecules, to determine the pathways potentially involved in
altered apoptosis.
Materials and Methods
Sample Collection
Intestinal mucosal and MAT samples, located near the affected
intestinal area, were taken from 10 patients with ileocecal CD who
underwent surgical resection [median age, 34.9 (range, 14–60)
years; 50% male]. We labeled as ICD group for intestinal mucosa
of CD patients and ACD for MAT of these patients. The presence
of disease activity was assessed by colonoscopy before surgery and
all patients had a Crohn’s disease activity index (CDAI) [22] of
more than 250 points. The control groups were composed of 8
patients who underwent intestinal resection for non-inflammatory
disease, with normal distal ileum (MAT control group – AC group)
[median age, 55.6 (range, 39–70) years; 62.5% male; 37.5%
female], and 8 patients with normal ileocolonoscopy (control
intestinal tissue group – IC group) [median age, 50.4 (range, 33–
60) years; 37.5% male; 62.5% female]. All CD patients and
healthy controls had body mass index, (weight in kilograms (kg)
divided by height in meters squared) (BMI) less than 25 points.
TUNEL Apoptosis Detection Analysis
For detection and quantification of apoptosis in the intestinal
mucosa and MAT samples, the TUNEL Apoptosis Detection
assay was performed (Terminal deoxynucleotidyl transferase
mediated dUTP nick end labelling) [23], using a kit from
Millipore (Billerica, MA). This assay is based on the marking of
DNA strand breaks by the technique of labelling of DNA with
terminal dUTP (FITC-conjugated). We used the protocol recom-
mended by the manufacturer. The nuclear staining was performed
with propidium iodide (PI). Photomicrographs were taken using a
Leica DM 4500B microscope and Leica DFC 290 digital camera
system with Leica Application Suite version 3.8 Software (Leica
Microsystems, Wetzlar). Three fields for each sample were
captured. Any cell type showing nuclear co-labeling (FITC+PI)
Figure 3. Immunohistochemical staining of Bax in the intestinal tissue (epithelium and lamina propria) of the Crohn’s disease group
(ICD) and in the mesenteric adipose tissue (MAT) of the Crohn’s disease group (ACD), compared to the respective control biopsy
samples (IC and AC). (A) Representative staining of fixed paraffin-embedded tissue of terminal ileum from IC and ICD groups showing fewer
positive cells (brown) in the lamina propria of ICD, compared to the IC group. (B) Representative staining of fixed paraffin-embedded mesenteric
adipose tissue in the AC and ACD groups; no differences were found among the groups. Images were obtained using a 40x objective. The positive
control was from tissue section of prostatic cancer. For ACD, n = 10; and for AC, n = 8. (C) Quantitative analysis of immunohistochemical staining for
Bax in the intestinal mucosa of the Crohn’s disease group (ICD), compared to the respective control (IC). The graphs show the quantitative analysis for
the epithelium and lamina propria immunostainings separately. For ICD, n = 10; for IC, n = 8, *p,0.05 vs control.
doi:10.1371/journal.pone.0098547.g003
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was considered positive for quantitative analysis, which was
analyzed by a blinded observer (C.B.D.), in a panchromatic
objective field of higher magnification 40X.
Histological Analysis (Hematoxylin - Eosin)
Biopsies from the mucosa of the terminal ileum and from the
MAT, near the affected intestinal area, were embedded in paraffin
blocks for histological analysis. Sections of 5 mm were cut and
stained with hematoxylin and eosin dye.
Photomicrographs were taken using a Zeiss Axiophot micro-
scope and Cannon Power Shot G5 digital camera system (Cannon
Inc., Tokyo). Fifty fields of higher magnification (40X) were
scanned for each sample and 10 random fields were analyzed. The
number of adipocytes was counted and their area and perimeters
were obtained. The morphometric results were quantified by a
blinded observer (C.B.D.) using the software Image J (Image
Processing and Analysis in Java, public domains, rsbweb.nih.gov/ij/
21).
Bax, Bcl-2 and Ki67 Immunohistochemical Staining
Histological sections of 5 mm were also performed for immu-
nostaining procedures of samples included in paraffin blocks.
Endogenous peroxidase was blocked with 3% hydrogen peroxide/
10 mM PBS pH 6.0 for 15 min. Afterwards, the sections were
microwaved in 3% milk buffer for 30 min and incubated
overnight with primary antibodies; anti-Bax (DAKO A/S Den-
mark; N-20 5c493, rabbit polyclonal), anti-Bcl-2 (DAKO A/S
Denmark; N-19 5c492, mouse polyclonal), anti-Ki67 (DAKO A/S
Denmark; F0788, mouse monoclonal) with dilutions of 1:600,
1:150 and 1:500 respectively at 20uC. The sections were incubated
with post primary block and secondary antibodies (Novocastra
Laboratories Ltd; Novolink RE 7260-K) for 1 h, and processed
using the DAB reaction (0.5 mg/ml, Sigma, USA, St Louis). Any
cell type showing cytoplasmic staining was considered positive for
quantitative analysis [11,24], which was performed by a blinded
observer (C.B.D.). The microscope and the software used to
capture images for quantitative analysis were the same as those
used for the hematoxylin and eosin study.
Caspase 3 Immunofluorescence Staining
Histological sections of 5 mm were also performed for immu-
nofluorescence procedures of samples included in paraffin blocks.
The preparation of slides was performed (deparaffinization and
hydration), followed by antigen retrieval. The tissue was incubated
in primary antibody anti-Caspase 3 (Santa Cruz CA; H-277: sc-
7148, rabbit polyclonal), with a dilution of 1:200 at 4uC overnight
and after with secondary antibody conjugated with FITC (goat
anti-rabbit IgG-FITC: sc-2012) in the same concentration for 1
hour. DAPI was used for nuclear staining. Any cell type showing
co-labeling in the cytosol for FITC were considered positive for
quantitative analysis [11], which was performed by a blinded
observer (C.B.D.). The microscope and the software used to
capture images for quantitative analysis were the same as those
used for the TUNEL study.
RT-PCR Analysis
Biopsies from the mucosa of the terminal ileum and from the
MAT, located near the affected intestinal area, were snap-frozen
in liquid nitrogen and stored at 280uC until use. Total RNA was
extracted using Trizol (Invitrogen), according to the manufactur-
Figure 4. Immunohistochemical staining of Bcl-2 in the intestinal tissue (epithelium and lamina propria) of the Crohn’s disease group
(ICD) and in the mesenteric adipose tissue (MAT) of the Crohn’s disease group (ACD), compared to the respective control biopsy
samples (IC and AC). (A) Representative staining of fixed paraffin-embedded tissue of terminal ileum from IC and ICD groups showing similar
numbers of positive cells (brown) in the ICD and IC groups. (B) Representative staining of fixed paraffin-embedded mesenteric adipose tissue from
the AC and ACD groups, showing a higher intensity in the ACD group, compared to the control (AC). Images were obtained using a 40x objective. (C)
and (D) Quantitative analysis of immunohistochemical staining for Bcl-2 of ICD and ACD groups, compared to the respective control groups (IC and
AC). The graphs of intestinal tissue show the quantitative analysis for the epithelium and lamina propria immunostainings separately. For ICD, n = 10;
for ACD, n = 10; for IC, n = 8; and for AC, n = 8, *p,0.05 vs control.
doi:10.1371/journal.pone.0098547.g004
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Figure 5. Representative Western blot analyses and determination of Bax and Bcl-2 protein expression in the intestinal tissue
(mucosa) of the Crohn’s disease group (ICD) and in the mesenteric adipose tissue (MAT) of the Crohn’s disease group (ACD),
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er’s instructions. RNA purity and concentration were determined
by UV spectrophotometry at 260 nm. RNA was treated with
RNase-free Dnase (RQ1 RNase-free Dnase, Promega) and then
reverse transcribed using oligo (dT) primers and reverse
transcriptase (RevertAid Kit, Fermentas). The reaction mixture
(20 ml) was incubated at 42uC for 60 min, then for 10 min at
70uC, and cooled on ice. RT-PCR was performed on resulting
cDNA, using the manufacturer’s protocol, in a 25 ml reaction
volume per capillary. Gene-specific primers (Applied Biosystems)
were: Hs00180269_m1 (Bax); Hs00608023_m1 (Bcl2);
NM_002046.3 (GAPDH). RT-PCR amplification consisted of an
initial denaturation step (50uC for 2 min and 95uC for 10 min), 40
cycles of denaturation (95uC for 15 s), annealing (53uC for 20 s)
and extension (72uC for 20 s), followed by a final incubation at
60uC for 1 min. All measurements were normalized by the
expression of GAPDH gene, considered as a stable housekeeping
gene. Gene expression was determined using the delta-delta Ct
method: 22DDCT (DDCT= [Ct(target gene)–Ct(GAPDH)]patient–
[Ct(target gene)–Ct(GAPDH)]control).
Real-time PCR analysis of gene expression was performed in a
7500 SDS sequence detection system (Applied Biosystems). The
optimal concentration of cDNA and primers, as well as the
maximum efficiency of amplification, were obtained by five-point,
two-fold dilution curve analysis for each gene. Real-time data were
analyzed using the Sequence Detector System 1.7 (Applied
Biosystems).
Immunoblotting – Gel Electrophoresis
For total protein extract preparation, the fragments of MAT,
which were previously snap-frozen and stored at 280uC, were
homogenized in solubilization buffer at 4uC [1% Triton X-100,
100 mM Tris-HCl (pH 7.4), 100 mM sodium pyrophosphate,
compared to the respective controls (IC and AC). Decreased expression of Bax was observed in ICD group, compared to the control group (IC),
and higher expression of Bcl-2, an anti-apoptotic protein, was observed in the MAT of Crohn’s disease (ACD) compared to the control group (AC). For
illustration purposes, each band represents one patient. For ICD, n = 10; for ACD, n= 10; for IC, n = 8; and, for AC, n = 8, *p,0.05 vs control.
doi:10.1371/journal.pone.0098547.g005
Figure 6. Immunofluorescence staining of Caspase 3 in the mesenteric adipose tissue (MAT) of the Crohn’s disease group (ACD)
compared to the respective control biopsy samples (AC). (A) Representative staining of fixed paraffin-embedded mesenteric adipose tissue
from the AC and ACD groups, showing a higher number of positive cells for FITC (green-fluorescent) in the cytosol, co-labeled with DAPI (nuclear
staining: blue-fluorescent) in the ACD group, compared to the control (AC). The arrows show the positive cells. Images were obtained using a 40x
objective. (B) Quantitative analysis of immunofluorescence staining for Caspase 3 of ACD group compared to the respective control group (AC). For
ACD, n = 10; for AC, n = 8, *p,0.05 vs control.
doi:10.1371/journal.pone.0098547.g006
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100 mM sodium fluoride, 10 mM EDTA, 10 mM sodium
orthovanadate, 2.0 mM phenylmethylsulfonyl fluoride (PMSF),
and 0.1 mg aprotinin/ml] with a Polytron PTA 20S generator
(model PT 10/35; Brinkmann Instruments, Westbury, NY)
operated at maximum speed for 30 sec. Insoluble material was
removed by centrifugation (20 min at 11000 rpm at 4uC). The
protein concentrations of the supernatants were determined by the
Bradford dye binding method. [25] Aliquots of the resulting
supernatants containing 50 mg total proteins were separated by
SDS-PAGE, transferred to nitrocellulose membranes and blotted
with anti-Bax and anti-Bcl-2 antibodies [26].
Reagents for SDS-PAGE and immunoblotting were from Bio-
Rad Laboratories (Richmond, CA). Phenylmethylsulfonyl fluoride,
aprotinin, Triton X-100, Tween 20, and glycerol were from Sigma
(St. Louis, MO). Nitrocellulose paper (BA85, 0.2 mm) was from
Amersham (Aylesbury, UK). The anti-Bax (sc-493, rabbit poly-
clonal) and anti-Bcl-2 (sc-492, rabbit polyclonal) antibodies were
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Molecular
weights of proteins were assessed using the PageRulerTM from
Fermentas (Glenburnie, MD). The signal was detected by a
chemiluminescent reaction (SuperSignal West Pico Chemilumi-
nescent Substrate from Pierce Biothecnology, Inc. Rockford, IL).
The results of blots are presented as direct comparisons of bands
in autoradiographs and were quantified by densitometry using the
Gel-Pro Analyzer 6.0 software (Exon-Intron Inc., Farrell, MD). All
results were normalized by b-actin.
Statistical Analysis
The Pearson’s regression coefficient (r) was used for correlations
between TUNEL results and morphometric data. A non-
parametric test (Mann-Whitney U, unpaired) was performed
using R Statistics Software (version 2.15.0) for statistical analyses to
compare the MAT of the CD group and its respective adipose
control group. The intestinal tissue of the CD group and its
respective intestinal control group were also compared separately.
The level of significance was set at p,0.05.
Ethical Considerations
The study was performed in accordance with the Declaration of
Helsinki and was approved by the Institutional Ethics Committee
of the Clinical Hospital of the Faculty of Medical Sciences
(University of Campinas, Sao Paulo, Brazil). All biopsies were
obtained after patients gave their written informed consent. In the
case of minors/teenagers enrolled in our study, parents or
guardians signed the informed consent on their behalf. All
consents forms are kept as hard copy. The study was carried out
in the Coloproctology Unit of the Surgery Department, and at the
Cell Signaling Laboratory of the Department of Internal
Medicine, University of Campinas.
Results
TUNEL Assay Reveals Altered Apoptosis in the Intestinal
Mucosa and in MAT of CD Individuals
The macroscopic increase of MAT close to the affected
intestinal area is a common feature in CD, in contrast to
observations in other inflammatory bowel diseases. Therefore, our
first objective was to determine, using TUNEL assay, the overall
rate of apoptotic cells in intestinal mucosa and MAT samples of
CD, and compare with their respective controls. This analysis
showed a significantly lower number of apoptotic cells in the ICD
and ACD groups, when compared to the respective control groups
(IC and AC) (p,0.05). A representative image of TUNEL assay is
shown in Figure 1 (A and C), where the apoptotic cells are well
identified in orange in the different groups. Figure 1 (B and D)
shows the quantitative analysis for all assessed samples.
Since we found an impaired apoptosis in the MAT of CD group
compared to controls, one of our aims was also to analyze the
morphometric characteristics of MAT, near the intestinal affected
area, and correlate these findings with the apoptotic index
(TUNEL). Figure 1 (E and F) demonstrates the histological aspect
(hematoxilin and eosin) and the mean perimeter and area of the
adipose cells of the AC and ACD groups. The adipocytes of the
ACD group presented a lower mean area and perimeter, when
compared to the controls (AC group) (p,0.05). There was a strong
positive correlation between the adipocyte area and perimeter with
the apoptotic index, as shown in Figure 1G. In addition,
immunohystochemistry for Ki67 was performed in all samples
from ACD and AC groups to access the proliferation rate of the
adipocytes and verify if this could be related to the morphometric
characteristics of MAT. However, no evidence of proliferation was
verified in MAT from both groups (Figure 1H).
Transcriptional Expression of Apoptosis-related Genes in
the Intestinal Mucosa and in MAT Reveals differences
between CD and Controls
Since alterations were detected in overall rate of apoptosis by
TUNEL in intestinal mucosa and in MAT of CD patients
compared to the controls, we decide to explore the molecular
mechanisms involved. Two relevant genes related to apoptosis
pathway were studied; Bax and Bcl2, which encode for a pro-
apoptotic and an anti-apoptotic protein, respectively. We found a
significant decrease of Bax transcriptional expression in the
intestinal mucosa of patients with CD, compared to the control
(p,0.05), while no differences were detected in MAT (p.0.05). In
addition, Bcl2 transcriptional expression was significantly de-
creased in the intestinal mucosa and in MAT in CD, when
compared to the respective controls (p,0.05). These findings are
shown in Figure 2.
Protein Analysis by Immunohistochemistry Confirms
Transcriptional Expression of Bax in the Intestinal Mucosa
of CD Patients
In order to validate our transcriptional finding we used
immunohistochemistry in the same samples used in PCR analysis.
Figure 3 (A and B) shows a representative picture of Bax staining
for intestinal tissue and MAT. A clear positive immunoreactivity
was observed for intestinal tissue, while MAT samples were all
negative. The quantitative analysis reveals a significant decrease in
Bax expression restricted in the lamina propria of CD patients,
clearly shown in Figure 3 (A and C), according with transcriptional
results. However, no differences were found in epithelium from
intestinal mucosa.
Immunohistochemical Protein Analysis Revealed a
Higher Expression of Bcl-2 in MAT of CD Patients
CD patients presented significantly higher protein expression of
Bcl-2 in MAT, compared to the controls, as seen in Figure 4 (B
and D). Positive immunoreactivity for Bcl-2 was also observed in
the intestinal mucosa (Figure 4A); however, quantitative analysis
showed no statistical difference between the groups (p.0.05)
(Figure 4C).
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Confirmation of the Expression of Bax and Bcl-2 Proteins
in the Intestinal Mucosa and in MAT of CD Patients by
Immunoblotting
Due to the conflicting data for Bcl2 transcriptional expression
and the immunohistochemistry study of Bcl-2, we assessed protein
expression by immunoblotting. The Bcl-2 anti-apoptotic protein
was found to be significantly more expressed in the MAT of CD
patients (ACD group), when compared to controls (AC group) (p,
0.05). No differences were detected in the intestinal mucosa
between the ICD and IC groups (p.0.05). See Figure 5.
Immunoblotting for Bax, shown in Figure 5, was also performed
in intestinal mucosa and MAT from CD and controls. The levels
of Bax were in accordance to the transcriptional results.
Caspase 3 Expression Confirms Defective Apoptosis in
MAT of CD Patients
To confirm the TUNEL and protein-related apoptosis expres-
sion results, immunofluorescence for Caspase 3 was performed.
The Caspase 3 was significantly less expressed in the MAT of CD
patients (ACD group), when compared to controls (AC group) (p,
0.05). Figure 6 illustrates this finding.
Discussion
Although phenotypic variation occurs in CD patients, some
common macroscopic aspects can be observed, especially with
regard to the thickening of the MAT close to the affected intestinal
area. This feature is not seen in patients with UC who develop a
superficial inflammatory process in the intestinal wall that is
usually restricted to the intestinal mucosa and submucosa layers.
[7,27] The adipose tissue is considered an important endocrine
organ, responsible for the production and release of hormones and
cytokines. [28] It is known that mesenteric adipocytes of normal
individuals are able to synthesize several pro-inflammatory and
anti-inflammatory cytokines, and express Toll-Like Receptor 4 for
the recognition of bacterial antigens. [29] These studies revealed
abnormalities in the MAT of CD patients, including the
infiltration of macrophages and T cells, perivascular inflammation,
fibrosis and differences in adipocytes number and size.
There are currently no studies regarding apoptosis in the MAT
of CD individuals, nor in the animal model of hypertrophied
MAT with associated colitis. [30] With this purpose in mind, we
used TUNEL assay to evaluate apoptosis in the intestinal mucosa
and in MAT, which revealed significantly fewer apoptotic cells in
CD, when compared to the control groups, not only in the
intestinal mucosa, but also in MAT. Intestinal barrier is
maintained due to balance rates of epithelial cell proliferation
and cell death. The literature has shown that healthy intestinal
mucosa has high rates of cell proliferation at the base of the
epithelium (crypt), with inhibition of signals to apoptosis, whereas
epithelial cells that compound the intestinal villi shows cell death
activation. This mechanism is not totally understood, but it seems
to be a shedding cell associated to cell death. [31–33] This explains
the high turn-over of the intestinal epithelial cells in homeostasis
conditions. In the present study, we found a low amount of
TUNEL-positive epithelial cells in CD compared to controls. This
may be explained by the presence of damaged mucosa consequent
to inflammation, where most part of the villi are lost. In this
situation, the remaining cells may be the ones that show low rate of
apoptosis and high rate of proliferation in order to recover the
affected area and restore function. Concerning the decreased
apoptosis in lamina propria cells of CD compared to the controls,
and the fact that part of these cells are immune cells, this confirms
previous published results in the literature [10,17].
In addition, the main novelty of our study was the correlation of
the number of apoptotic cells in MAT, as evidenced by TUNEL,
with reduced adipocyte size. Peyrin-Biroulet et al. [8] previously
described the morphometric features of the adipocytes from
hypertrophied CD MAT relating that these cells were small in size
and four times higher in number when compared to control
adipose tissue. However, these authors did not correlate these
findings with apoptosis. Figure 1G shows the significant correla-
tion between the morphometric parameters (perimeter and area)
of the adipose cells and the number of the apoptotic cells in the
MAT of CD and controls. These findings may explain, at least in
part, the intriguing features of MAT in CD: the thickening of this
tissue may be due to a resistance of adipose cells to undergo
apoptosis, leading to an increased number of adipocytes that
exhibit a lower perimeter and area than the control group. NF-KB
activation is one of the mechanisms described that can inhibit
apoptosis by inducing Bcl-2 expression (anti-apoptotic protein).
[34,35] High levels of NF-KB activation are verified in CD
[36,37]. This factor is responsible for activate transcription of a
large number of genes related to inflammation, among them,
TNF-a transcription. This may explain the resistance to apoptosis
in MAT of CD patients. We did not verify positivity for Ki67 in
MAT from CD patients and controls. This result is in accordance
with what is described in the literature concerning fat cell turn
over in humans. In non-obese conditions, adipose cells are not
prone to proliferation. Adipocytes proliferation (hyperplasia)
occurs only in severe cases of obesity, while hypertrophy occurs
across all obese states. [38] All CD patients included in the present
study, as well as the healthy controls were not obese, presenting
BMI (body mass index) less than 25.
To describe the molecular mechanisms involved with the
defective apoptosis detected by TUNEL, we studied Bax and Bcl2
transcripts and also the respective encoded proteins in the
intestinal mucosa and MAT of CD patients. Itoh et al. found
low levels of Bax in CD lamina propria T cells, using flow cytometric
analysis, when compared to UC and controls, indicating a
resistance to apoptosis in CD. [10] In the present study, we
report findings of low transcript and protein levels of Bax in the
intestinal mucosa of CD, compared to the control intestinal
mucosa. Moreover, we observed that the low protein levels of Bax
(as seen by immunohistochemistry) were localized in the lamina
propria, and not in the epithelium. Although there was low
transcriptional expression of Bcl2 in the ICD group, no differences
were observed with regard to Bcl-2 protein expression, as analyzed
by immunohistochemistry in this group. These findings reinforce
the data of Itoh et al. [10] and Santaolalla et al. [17], who
associated the defective apoptosis in the lamina propria to the Bax-
related pathways.
A defective apoptosis was also seen in the MAT of CD. This
apoptosis correlated significantly with high levels of Bcl-2 and
Caspase 3, and not with Bax protein expression. The low Bcl2
transcriptional expression observed in association with higher
protein MAT levels of Bcl-2 (as detected by immunohistochemistry
and immunoblotting) in the ACD group could be explained by
cytosine methylation, which greatly increases the stability of the
Bcl2 promoter (as described by Lin et al. [39]). Another possibility
is that high Bcl-2 protein levels could induce a negative feedback
control of Bcl2 gene transcription. The decreased expression of
Caspase 3 in MAT of ACD group compared to the control (AC
group) confirmed an altered apoptosis in this tissue.
The point of our study is to present new data that may help to
explain the singular characteristics of MAT in CD patients. Given
the current emphasis that has been given to the role of adipose
tissue in gut homeostasis and inflammation [40], the defective
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apoptosis of MAT in CD may explain the high survival rate of
these cells, which in large amount may express higher levels of pro-
inflammatory mediators. For instance, significantly higher expres-
sion of C-reactive protein (CRP), an inflammatory marker, was
detected in the MAT of CD compared to UC and controls. [41]
Moreover, a comparison of adipocyte gene expression from MAT
of CD and in healthy individuals showed up-regulation of pro-
inflammatory genes and decrease of genes involving lipid
metabolism [21].
MAT may have an important role in the maintenance of
inflammation in CD, since the altered balance between pro-
inflammatory and anti-inflammatory factors in this tissue, as well
as defective autophagy, have been previously reported in the
literature. [5,42–48] Among these studies, one of them verified
lower levels of adiponectin (anti-inflammatory properties) in
peripheral serum and in MAT of active CD patients, revealing
deficient anti-inflammatory conditions. [43] Moreover, this tissue
may be involved in the maintenance of inflammation in the late
stages of the disease, and in the mechanism that leads to relapses
during the course of the disease. Therefore, the decreased
apoptosis revealed in the present study, associated with already
published previous data that have shown the capacity of the
adipose cells to produce cytokines and its plasticity [42,44,49],
could lead to insights for further research that may explain the
complete role of MAT in CD.
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